Detalhe da pesquisa
1.
Immunomodulatory kits generating leukaemia derived dendritic cells do not induce blast proliferation ex vivo: IPO-38 as a novel marker to quantify proliferating blasts in acute myeloid leukaemia.
Clin Immunol
; 242: 109083, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908638
2.
Generation of Leukaemia-Derived Dendritic Cells (DCleu) to Improve Anti-Leukaemic Activity in AML: Selection of the Most Efficient Response Modifier Combinations.
Int J Mol Sci
; 23(15)2022 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955486